Usefulness of C-Reactive Protein as a Marker for Prediction of Future Coronary Events in the Asian Indian Population: Indian Atherosclerosis Research Study

Table 4

Risk of recurrence of coronary artery disease (CAD) events based on high-sensitivity C-reactive protein (hsCRP) quartiles.

		hsCRP quartile
		1 (<0.7 mg/L)	2 (0.71–1.7 mg/L)	3 (1.71–3.57 mg/L)	4 (>3.58 mg/L)	𝑃
Model 1	OR (95% CI)	1	1.219 (0.406–3.656)	2.541 (0.954–6.773)	3.793 (1.454–9.898)	.019
	𝑃		.724	.062	.006
Model 2	OR (95% CI)	1	1.194 (0.395–3.614)	2.585 (0.947–7.054)	3.903 (1.411–10.8)	.029
	𝑃		.753	.064	.009
Model 3	OR (95% CI)	1	1.790 (0.406–7.882)	3.363 (0.806–14.04)	4.359 (1.023–18.573)	.17
	𝑃		.441	.096	.047
Model 4	OR (95% CI)	1	1.071 (0.346–3.316)	1.958 (0.695–5.517)	3.204 (1.113–9.227)	.093
	𝑃		.905	.204	.031
Model 5	OR (95% CI)	1	1.115 (0.363–3.429)	1.814 (0.636–5.172)	3.106 (1.07–9.014)	.131
	𝑃		0849	.265	.037

Model 1: Unadjusted.
Model 2: Adjusted for hypertension, diabetes, gender, age, and body mass index.
Model 3: Additional adjustment for interlukin-6*
Model 4: Additional adjustment total cholesterol, high-density lipoprotein (HDL) and triglyceride*.
Model 5: Additional adjustment total cholesterol, HDL, triglyceride* and low-density lipoprotein.
*log-transformed distribution.
OR: odds ratio; CI: confidence interval.